We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Early Stage Melanoma Identified by Simple Blood Test

By LabMedica International staff writers
Posted on 20 Sep 2017
Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. More...
Melanomas typically occur in the skin but may rarely occur in the mouth, intestines, or eye.

Melanoma is an aggressive cancer and once it has spread through the body, average survival is six to nine months, with less than 40% of patients surviving five years. New Zealand and Australia have the highest incidence of melanoma in the world. More than 2,400 New Zealanders a year are diagnosed with melanoma and around 350 New Zealanders die from it every year.

Scientists at the Edith Cowan University (ECU, Perth, Australia) have developed blood-based biomarkers for early diagnosis, prognosis and personalization of treatment in melanoma. Through the implementation of cutting-edge technologies and next generation sequencing the team scrutinized novel biomarkers such as Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA). In addition, they expanded the study of miRNA, exosomes and autoantibodies for improved specificity and sensitivity. The technologies are now being expanded to include prostate, breast and lung cancers. The team is also monitoring the DNA of patients who finish treatment to see if they remain disease-free.

Mel Ziman, PhD, associate dean and head of the ECU Melanoma Research Group, said, “At the moment, suspicious lesions are biopsied and examined by a pathologist. In some cases diagnosis is difficult and not always certain, particularly with very early melanomas and those without color. We’ve identified several auto antibodies that are produced by the body in response to melanoma and have developed a one-step blood test that will search for any one of these identifiers, which provides rapid, diagnostic certainty.” The study was presented a meeting titled “Melanoma research and therapy in New Zealand: raising the bar through collaborative action” held on September 9, 2017, in Queenstown, New Zealand and organized by Melanoma New Zealand.

Related Links:
Edith Cowan University


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Rapid Test Reader
DIA5000
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.